First Person Authorization (i.e., donor designation) legislation makes indicating one's intent to be a posthumous organ donor legally binding, much like a living will or advance directive. Such legislation is the most recent in a long history of organ donation policies in the United States and has received little attention in the literature.
I
n the half century since the first successful kidney transplant, only modest progress has been made toward increasing the number of organ donations in the United States. In 1988, when data first became available, organs were recovered from 4,080 deceased Americans. Since then, this figure has doubled, with 8,127 deceased donors recovered in 2011. 1 During this same period, however, the number of critically ill patients awaiting an organ transplant increased exponentially. Whereas 25,000 patients with end-stage organ failure were on the waitlist in 1988, today, there are more than 114,000 waitlisted patients. 1 The marked wait time increases have not only been attributed to improved immunosuppressant therapies and surgical techniques that, in turn, have improved the likelihood of successful transplantation 2,3 but also to the growing incidence of end-stage renal failure in the United States, 4 for which transplantation is preferred over prolonged dialysis because of its comparatively lower cost and improved patient survival and quality of life.
5Y7 Recent data reveal, however, that from 2007 to 2009, the number of living and deceased organ donors dropped substantially. 8 Although this decrease may be an anomaly, even a small loss of donors equates to the potential loss of eight transplantable organs per donor and the concomitant loss of human life.
First Person Authorization or ''donor designation'' is the most recent in a long line of regulatory efforts attempting to bridge the ever-increasing divide between the supply of transplantable organs and their demand. First Person Authorization makes the indication of an adult's intent to donate some or all organs and/or tissue via a driver's license, a donor card, or other documents legally binding. Enactment of this legislation necessitates changes in the way in which organ procurement organizations (OPOs) approach families of patients whose expressed desire was to become an organ donor at death. Rather than requesting family permission for donation, OPOs must now inform families of the patient's decision to donate. Currently, all 50 states, the District of Columbia, and the US Virgin Islands have enacted the legislation.
longitudinal study (N = 569) in Virginia found that families of designated donors (n = 162; 28.5%) reported more donationrelated communication with the deceased and higher awareness of the decedent's donation wishes and organ donation in general as compared with other families approached about the option of solid organ donation. 10 Moreover, few designated donor families reported stress surrounding the approach for organ donation, and most were comfortable with the decedent's decision to donate. Similarly, a 5-year evaluation of an educational campaign promoting First Person Authorization in Ohio found most respondents stating that donors' wishes should be respected and implemented over family objection. 11 Finally, a cross-sectional study of 561 (348 donors, 213 nondonors) Floridians approached about donation reported greater support for the policy and stronger agreement that family permission was not needed among donors as compared with nondonors. 12 The research reported here extends previous work by examining a nationwide sample of individuals who were approached about the option of deceased organ donation. Our purpose was to compare organ donation knowledge, attitudes, and behaviors of families of designated donors with individuals whose families did not have documentation of the patients' wishes. We also compared the donation process and examined the effectiveness and acceptability of donor designation legislation.
PATIENTS AND METHODS

Study Sites
Nine OPOs representing geographically diverse areas of the United States (i.e., New England, Northeast, Mid-Atlantic, South, Midwest, and West) were invited to participate as study sites. All agreed to the collaboration. OPO staff responsible for approaching families of potential donor-eligible patients and requesting donation were enrolled in the study. After each family contact for which a decision about organ donation was made, participating requesters completed an online survey to collect patient and surrogate decision maker (i.e., family) information. Data collection spanned from January 2009 to June 2011. First Person Authorization legislation was enacted in each region before data collection.
Family Sample
A letter describing the nature and purpose of the study was sent to family decision makers (N = 1,391) approached about the option of donating organs. Each letter also provided instructions for opting out of the research. To allow families time to grieve, the letters were sent 2 months after the death of adult patients and 3 months after the death of pediatric patients, a procedure we have used in past research. 13, 14 Telephone interviews were conducted with 1,090 families agreeing to participate. The sample included 839 families (77.0%) who did not have donor designation (718 families authorized donation, 121 refused donation) and 251 (23.0%) families of designated donors. An overall response rate of 78.4% was obtained for this study. The study received approval from the Virginia Commonwealth University Institutional Review Board.
Informed consent was obtained from both OPO request staff and family participants.
Family Interview
Seven research staff were extensively trained to conduct the family interviews during a period of 2 months. The interviews consisted of a series of structured and semistructured questions capturing a variety of aspects of the request for organ donation, including attitudes toward First Person Authorization and satisfaction with the donation request process. The interview, with corresponding measures, has been well validated and used in previous studies examining organ and tissue donation. 13Y15 The specific measures included in the interview are described in detail below. Higher scores indicate higher levels of each measured variable.
Organ Donation Attitudes
Attitudes toward organ donation were assessed using five-point Likert-type scales drawn from the Attitudes Toward Organ Donation Scale 16,17 asking respondents to indicate their level of agreement with 17 statements; individual items were summed to compute a global attitude score that ranged from 17 to 85. Internal consistency reliability for the scale was mediocre (Cronbach's > = 0.44).
Organ Donation Knowledge
Knowledge of organ donation was measured using four true or false questions; correct responses were summed to create a global knowledge score.
Initial Reaction to the Request
A categoric item assessed initial reactions to the idea of organ donation (favorable/unfavorable/mixed). One dichotomous (yes/no) question gauged families'surprise at the request for organ donation.
Time Discussing Donation
Respondents were also asked to report the total amount of time spent discussing organ donation and donation-related issues; satisfaction with the length of the discussion was measured on a seven-point Likert-type scale.
Perceptions of Requesters' Communication
A shortened version of Burgoon and Hale's Relational Communication Scale 18 was used to capture respondents' perceptions of requesters' relational communication skill during the request for donation along 12 seven-point Likert-type scales of agreement. A single five-point item also asked decision makers to rate the quality of the requesters' communication during the donation discussion. Another seven-point item assessed whether respondents felt pressured or harassed into donating.
Decisional Comfort
Two items assessed respondents' decisional regret. The first, a seven-point Likert-type item, asked participants to indicate their level of comfort with the donation decision. The second asked whether participants would make the same decision about donation (yes/no).
Satisfaction With Request
One seven-point Likert-type item assessed satisfaction with the request process.
First Person Authorization
A series of questions were posed to gauge the families' awareness of and reactions to patients' decisions to donate posthumously. Specifically, three dichotomous (yes/no) items assessed families' awareness of the patient's status as a donor, comfort with the manner in which this information was given, and stress experienced as a result of being informed about the decision. Two open-ended questions allowed respondents to elaborate on their responses.
Demographic Characteristics
Sociodemographic information, including sex, age, ethnicity, race, and income, was collected from all participants.
Data Analysis
Summary statistics (i.e., means, SDs, frequencies, percentages) were used to characterize the overall sample as well as the three subgroups: family participants who (1) authorized donation, (2) declined donation, and (3) families of designated donors. The appropriate tests of association were performed (e.g., analysis of variance, W 2 ) to examine the relationship between the primary outcome variable (i.e., authorization/refusal/donor designation) and the other study variables; Tukey's post hoc comparisons were performed to pinpoint where differences between groups occurred. Analyses were performed using IBM SPSS Statistics 19.
RESULTS
Sample
Overall, the sample was primarily composed of white (77.5%; 16.0% African American, 2.9% multiracial, 2.1% other, 1.5% unknown) females (68.9%) and self-reported Protestant religious affiliation (38.2%) who were raised in the continental United States (91.1%); approximately 15% (14.9%) of the sample self-identified as Hispanic/Latino(a). On average, surrogate family decision makers were aged 48 years (SD, 13.9 years) and had 14 years of education (SD, 2.3 years). Although most participants reported a willingness to donate their own organs at death (86.3%), only one half (50.6%) of those interviewed were registered organ donors. See Table 1 for a complete description of the sample.
Organ Donation Decisions
Family decision makers of patients who had or had not designated themselves as donors differed significantly. As would be expected, designated donors were much more likely to become donors; 97.6% of designated donor families donated compared with 85.6% of other families. This meant that despite the designation, 6 of 251 countermanded the patient's decision to donate. Although First Person Authorization legislation is intended to uphold personal autonomy in the choice to become a posthumous organ donor, there is currently no penalty for families who override patients' decisions and do not donate. Although some OPOs will uphold decedents' wishes in the face of family dissent, others choose not to procure out of habit and/or to prevent negative publicity. The differences between the families of patients who designated themselves as donors (First Person Authorization) and the nondesignated families who chose to donate (NDD) and those who refused donation (NDR) will be the focus of the remainder of this article.
Demographic Comparison
Significant differences were found in the demographic characteristics of the three subgroups of families. Specifically, First Person Authorization families were less likely to be of Hispanic/Latino ancestry (W Table 1 ).
Organ Donation Attitudes and Knowledge
Knowledge of organ donation was high, with 1,075 (98.6%) of participants answering at least one half of the items correctly. Overall, families demonstrated the least knowledge regarding the implications of donor designation on organ, tissue, and eye donation (Fig. 1) . That is, approximately 20% of families did not understand that designating oneself as an organ donor also committed them to the posthumous donation of tissues (e.g., skin, bone, heart valves, etc.) and eyes (e.g., cornea, sclera, whole eye). NDRs, however, exhibited the highest degree of knowledge about this item. In addition, significant differences were found in the proportion of correct responses for each item and in the global knowledge scores between subgroups (F 2, 1,087 = 4.5, p = 0.01). Specifically, NDDs and designated donor families displayed equally more knowledge of organ donation overall (mean, 3.5; SD, 0.7) than did NDRs (mean, 3.3; SD, 0.9).
On average, respondents expressed positive attitudes toward organ donation (mean, 64.3; SD, 7.1) (see Table 2 ). However, significant mean differences in global attitude scores were found between subgroups (F 2, 1,087 = 12.5, p G 0.001), with both NDDs and designated donor families exhibiting significantly more favorable attitudes than NDRs (mean, 64.5 and 64.9 vs. 61.3). As compared with families who were faced with making the decision about donation, a larger percentage of designated donor families found solace in organ donation, understood the implications of brain death, and were comfortable with health care providers' knowledge of their willingness to donate organs posthumously. These families, however, were less likely to support monetary payments to donor families, the concept of directed donation, or recovering organs from registered donors without family permission. Table 3 presents respondents' perceptions of a variety of aspects of the request process. Overall, families of designated donors had more favorable perceptions of the request for organ donation. For instance, as compared with other families sampled, significantly fewer designated donor families were surprised at the request for donation (W 
Perceptions of the Request for Donation
Impact of Donor Designation on Families' Emotional Well-Being
Almost two thirds (65.7%) of the designated donor families were aware of the decedent's decision to register as a posthumous donor. Of the families who were unaware (n = 86), 12 (14.0%) were not comfortable with the manner in which they were informed of the patient's status as a registered donor. The most commonly cited complaints were the timing (e.g., being told right after patient was declared brain dead or before being informed of the patient's condition) and mode (e.g., emergency medical technicians) of delivery and requesters' communication of the information. In addition, 12 (14.0%) families noted that the information added to their stress because of lack of family communication regarding the patient's donation wishes, the family's position against organ donation, and the use of life supports to maintain the patient for donation purposes. A small number (2.4%) of designated donor families refused donation. This figure is considerably lower than the 20% refusal rate found in one single-site study. 19 On request, four were initially favorable toward the idea of organ donation, one was unfavorable, and one was unsure. The reasons offered for refusal included family exhaustion, dissatisfaction with the patient's care, disagreement about donation, and issues surrounding the delay or maintenance of life supports. None stated that they believed the patients had changed their minds about donation or had not designated their wishes accurately.
DISCUSSION
Unlike other regulatory efforts to increase the number of organ donors in the United States and the number of organs available for transplant, the enactment of First Person Authorization legislation was firmly grounded in a body of empirical evidence that knowledge of patients' wishes regarding solid organ donation not only aids families in their decision making but also increases the likelihood of familial authorization and satisfaction with the final donation decision. 20Y25 Our results provide additional support for this legislative approach and offer assurances that this policy does not add additional stress to already bereaved families. Of note are findings that families of designated donors report having a more positive experience with the organ donation request process overall and greater comfort and satisfaction with the donation decision than others.
Although more than one third of the families of registered donors were not aware of the patient's decision to donate posthumously, the donation decision was overwhelmingly accepted. A minority of these families (17%), however, expressed dissatisfaction with the way in which they were notified of the patient's status as a donor. For example, on learning of the patient's decision from an OPO requester and reacting with surprise, one respondent reported being told, ''you don't know him too well.'' Such a response likely caused the family additional distress during a time marked by stress, anxiety, and grief. Clearly, all health care providers and OPO request staff should be provided training on how to modify their approach with designated donor families. Notification of the patients' decision should be done with tact and sensitivity. Specifically, OPO staff should ''provide continuing support and care for the donor family while guiding them toward an understanding of their loved one's wishes.'' 26 Request staff seem to be successful at this, with some notable exceptions. Continued efforts to educate the public about the benefits of organ donation and the critical importance of family communication surrounding the topic, particularly with regard to the act of designating oneself as a donor, are needed as well.
Although this research is the first to examine in-depth the attitudes and behaviors for designated donor families in a national sample, it is not without limitation. Significant differences were found in the demographic characteristics between the three subgroups under examination. Families of registered donors were more likely to be white and to hold more years of education than other families sampled; they were also more willing to donate their own organs and to be a registered organ donor. These findings are consistent with past research documenting positive associations between status as an organ donor and willingness to donate with white race and more years of education. 27 ,28 The study's major limitation is the smaller number of families refusing donation. This reflects the myriad of challenges associated with contacting and recruiting families who refused to donate, including incomplete and/or Values are expressed as mean (SD) unless noted otherwise. *W 2 test statistic significant at > = 0.001 level. †Values are expressed as n (%). ‡Significant differences between authorizing and refusing families. §Significant differences between donor designation families and families refusing donation. ||Significant differences between all three subgroups. completely missing contact information, transience, and negative experiences with the patient's care and/or the request for donation. Finally, although our participation rate was high (74.3%), we were unable to collect information on families declining participation aside from their donation decision; significantly more NDRs (49.4%) declined participation in the research than NDDs/designated donor families (16.1%; W 2 1 = 128.0, p G 0.001). As noted above, statistically significant differences between families authorizing to donate and those refusing donation have been documented. Therefore, our findings may contain some degree of nonresponse bias, although very few families who did not donate were those whose loved ones had designated themselves as donors.
This study is the first national examination of the effects of First Person Authorization legislation on the organ donation request process. The study provides strong evidence that this policy can and is being successfully and sensitively implemented. We maintain that, at least in the US context, First Person Authorization, which places a premium on individual autonomy, is ethically and culturally preferable to approaches that fail to acknowledge population diversity (e.g., presumed consent) or commoditize the organ donation process (e.g., monetary incentives for donation).
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